NTRA – natera, inc. (US:NASDAQ)
Stock Stats
News
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $200.00. They now have an "overweight" rating on the stock.
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer [Yahoo! Finance]
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment [Yahoo! Finance]
Form 4 Natera, Inc. For: Dec 18 Filed by: Sheena Jonathan
Form 144 Natera, Inc. Filed by: Sheena Jonathan
Form 4 Natera, Inc. For: Dec 13 Filed by: Rabinowitz Matthew
Form 144 Natera, Inc. Filed by: Rabinowitz Matthew
Form 4 Natera, Inc. For: Dec 10 Filed by: Chapman Rowan E
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.